Previous 10 | Next 10 |
HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics to Present at 3 rd Annual mRNA-Based Therapeutics Summit Altamira’s two flagship programs, AM-401 and AM-411, designed for KRAS-driven cancer and rheumatoid arthritis, serve to demonstrate the t...
2023-12-29 08:53:57 ET More on Altamira Therapeutics Altamira shares sink over 40% on corporate, stock split updates Altamira stock rallies 130% in wake of Nasdaq update, unit sale For further details see: Altamira Therapeutics stock rises after it regains compli...
HAMILTON, BERMUDA, Dec. 29, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA, Dec. 29, 2023 -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, announced that it received a noti...
2023-12-14 05:51:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Altamira Therapeutics (NASDAQ: CYTO ) just reported results for the first half of 2023. Altamira Therapeutics reported earnings per share of -$28.20. The company repor...
2023-12-13 14:01:03 ET Altamira Therapeutics Ltd. (CYTO) Special Call December 11, 2023, 08:30 AM ET Company Participants Thomas Meyer - Founder, Chairman and CEO Conference Call Participants Presentation Operator Good morning, and welcome to ...
2023-12-11 10:25:29 ET More on Altamira Therapeutics Altamira Therapeutics Ltd. (CYTO) Q2 2023 Earnings Call Transcript Altamira stock rallies 130% in wake of Nasdaq update, unit sale Altamira stock surges after deal to sell 51% stake in Medica Financial info...
HAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ET Partial spin-off of Bentrio® business first step in transition to become ‘pure play’ RNA delivery company Transition ...
HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA--December 5, 2023--Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an Inves...
2023-11-30 10:11:39 ET DENVER, Colo., Nov. 30, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Atara Biotherapeutics Inc (NASDAQ: ATRA), Minim Inc (NASDAQ: MINM), Altamira Therapeutics Ltd (NASDAQ: CYTO),...
2023-11-29 13:22:36 ET More on Altamira Therapeutics Altamira Therapeutics Ltd. (CYTO) Q2 2023 Earnings Call Transcript Altamira stock surges after deal to sell 51% stake in Medica Financial information for Altamira Therapeutics For further details see: A...
News, Short Squeeze, Breakout and More Instantly...
Altamira Therapeutics Ltd. Company Name:
CYTO Stock Symbol:
NASDAQ Market:
Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd. (“Altamira” or t...
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of improvement in nasal symptoms (p = 0.013) Corroborated ...
Hamilton, Bermuda, April 10, 2024 (GLOBE NEWSWIRE) -- Management to host conference call today, April 10, at 8.30 a.m. EDT RNA delivery business progressing with new collaborations, potential new applications Partnering of legacy assets underway as Company transitions to f...